ReviewIndian journal of surgical oncology2024
Understanding Biologically Guided Radiotherapy: Essential Insights for Surgical Oncologists.
Review in Indian journal of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PSMA PET-directed radiotherapy for prostate cancer: From precision planning to future innovations.View (Beijing, China) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The technology in the radiotherapy field is approaching a new evolution day by day. The image-guided radiotherapy (IGRT) approach has changed the radiotherapy treatment workflow scenario. The image acquired before radiotherapy treatment helps minimize uncertainty in target positioning for accurate radiation delivery. Biologically guided radiotherapy (BgRT) is a new approach in radiotherapy through the IGRT modality to track the target with the help of radiopharmaceuticals. It acquires the image through PET-CT and attaches it to a linear accelerator before treatment to verify the target volume. BgRT, a pioneering technology, stands out with its unique ability to adapt dose delivery based on biological features, which sets it apart from conventional IGRT. By utilizing PET detection, BgRT can rapidly adjust the position of the linear accelerator to accommodate target motion, enabling precise dose delivery while sparing surrounding normal tissues. This represents a significant advancement, allowing for real-time tracking and adjusting radiation doses according to biological changes within the tumor. Additionally, a single tracer injection and a single treatment plan can effectively target multiple metastatic lesions, streamlining the treatment process. However, due to radioactive tracer uptake, BgRT is more suitable for hypo-fractionated or stereotactic treatments than conventional fractionation. This article provides an overview of the technological advancements of BgRT and their clinical implications in modern radiation oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.